The Positive Effects of One-Hour Intravenous Administration of Bortezomib on Peripheral Neuropathy in Multiple Myeloma Patients

Bortezomib-induced peripheral neuropathy (BiPN) in multiple myeloma (MM) patients is a common and serious side effect. Currently, it has been reported that subcutaneous (SC) administration of bortezomib decreases the incidence of BiPN as compared to standard intravenous (IV) bolus injection without...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Joo Young, Kim, Ho Young, Han, Boram, Choi, Dae Ro, Zang, Dae Young, Kim, Hyo Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065765/
https://www.ncbi.nlm.nih.gov/pubmed/24995276
http://dx.doi.org/10.1155/2014/237698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065765/
https://www.ncbi.nlm.nih.gov/pubmed/24995276
http://dx.doi.org/10.1155/2014/237698

Ejemplares similares